Topas in the news – Topas Therapeutics https://topas-therapeutics.com Transforming the field of immune tolerance Tue, 19 May 2026 17:47:02 +0000 en-US hourly 1 https://wordpress.org/?v=6.9.4 European Pharmaceutical Review – The Promise and Hurdles of Restoring Immune Tolerance https://topas-therapeutics.com/european-pharmaceutical-review-the-promise-and-hurdles-of-restoring-immune-tolerance/ Tue, 19 May 2026 17:00:54 +0000 https://topas-therapeutics.com/?p=1958 Go to Article

[linkedin]


]]> Drug Target Review – Women in STEM with Cristina de Min https://topas-therapeutics.com/drug-target-review-women-in-stem-with-cristina-de-min/ Tue, 19 May 2026 16:57:43 +0000 https://topas-therapeutics.com/?p=1955 Go to Article

[linkedin]


]]> Going Public -“We still believe we’re an undiscovered gem” Charting the Future of Immune Tolerance: Insights from the CEO of TOPAS https://topas-therapeutics.com/going-public-we-still-believe-were-an-undiscovered-gem-charting-the-future-of-immune-tolerance-insights-from-the-ceo-of-topas/ Tue, 19 May 2026 16:56:10 +0000 https://topas-therapeutics.com/?p=1947 Go to Article

[linkedin]


]]> Endpoints News – Exclusive: Topas claims success in early test of ‘immune tolerance’ therapy for celiac disease. https://topas-therapeutics.com/endpoints-news-exclusive-topas-claims-success-in-early-test-of-immune-tolerance-therapy-for-celiac-disease/ Tue, 19 May 2026 16:46:54 +0000 https://topas-therapeutics.com/?p=1898 Go to Article

[linkedin]


]]>